FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308015771> ?p ?o ?g. }

• W4308015771 endingPage "e0275392" @default.
• W4308015771 startingPage "e0275392" @default.
• W4308015771 abstract "To evaluate the efficacy and safety of cilostazol, pentoxifylline, beraprost for intermittent claudication due to lower extremity arterial occlusive disease.Randomized controlled clinical trials were identified from PubMed, Scopus, EMbase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, SinoMed, Wanfang and Chongqing VIP databases, from the database inception to 31/12/2021. The outcome measures were walking distance measured by treadmill (maximum and pain-free walking distance), ankle-brachial index and adverse events. The quality of included studies was assessed by the Cochrane bias risk assessment tool. A network meta-analysis was carried out with Stata 16.0 software.There were 29 RCTs included in the study, covering total 5352 patients. Cilostazol was ranked first for both maximum and pain-free walking distance, followed by beraprost and pentoxifylline. For cilostazol, pentoxifylline and beraprost, maximum walking distance increased by 62.93 95%CI(44.06, 81.79), 32.72 95%CI(13.51, 55.79) and 43.90 95%CI(2.10, 85.71) meters, respectively relative to placebo, and pain-free walking distance increased by 23.92 95%CI(11.24, 36.61), 15.16 95%CI(2.33, 27.99) and 19.78 95%CI(-3.07, 42.62) meters. For cilostazol, pentoxifylline, beraprost and cilostazol combined with beraprost, ankle-brachial index increased by 0.06 95%CI(0.04, 0.07), -0.01 95%CI(-0.08, 0.05), 0.18 95%CI(0.12, 0.23) and 0.23 95%CI(0.18, 0.27), respectively relative to placebo. The pentoxifylline and cilostazol was associated with a lower ratio of adverse events than beraprost and cilostazol combined with beraprost.Cilostazol, pentoxifylline and beraprost were all effective treatments for intermittent claudication; cilostazol with good tolerance was likely to be the most effective in walking distance, while beraprost and cilostazol combined with beraprost were more prominent in the ankle-brachial index." @default.
• W4308015771 created "2022-11-07" @default.
• W4308015771 creator A5045755790 @default.
• W4308015771 creator A5074133814 @default.
• W4308015771 creator A5080337025 @default.
• W4308015771 creator A5090814462 @default.
• W4308015771 date "2022-11-01" @default.
• W4308015771 modified "2023-10-14" @default.
• W4308015771 title "Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis" @default.
• W4308015771 cites W1592090008 @default.
• W4308015771 cites W161145863 @default.
• W4308015771 cites W1695362599 @default.
• W4308015771 cites W1863568658 @default.
• W4308015771 cites W1965470038 @default.
• W4308015771 cites W1973101407 @default.
• W4308015771 cites W1984011921 @default.
• W4308015771 cites W1989479013 @default.
• W4308015771 cites W1991983629 @default.
• W4308015771 cites W1997451914 @default.
• W4308015771 cites W1998156657 @default.
• W4308015771 cites W1998724522 @default.
• W4308015771 cites W2002893478 @default.
• W4308015771 cites W2003619955 @default.
• W4308015771 cites W2022126933 @default.
• W4308015771 cites W2028737104 @default.
• W4308015771 cites W2036562409 @default.
• W4308015771 cites W2037187586 @default.
• W4308015771 cites W2052395633 @default.
• W4308015771 cites W2057244473 @default.
• W4308015771 cites W2061799681 @default.
• W4308015771 cites W2066924209 @default.
• W4308015771 cites W2070488805 @default.
• W4308015771 cites W2077013906 @default.
• W4308015771 cites W2077302438 @default.
• W4308015771 cites W2079029234 @default.
• W4308015771 cites W2082352316 @default.
• W4308015771 cites W2090479065 @default.
• W4308015771 cites W2091845048 @default.
• W4308015771 cites W2117838742 @default.
• W4308015771 cites W2118848766 @default.
• W4308015771 cites W2133111496 @default.
• W4308015771 cites W2157276089 @default.
• W4308015771 cites W2169205464 @default.
• W4308015771 cites W2329086250 @default.
• W4308015771 cites W2581503010 @default.
• W4308015771 cites W2615539025 @default.
• W4308015771 cites W2767350488 @default.
• W4308015771 cites W2947016149 @default.
• W4308015771 cites W2980138849 @default.
• W4308015771 cites W3109445910 @default.
• W4308015771 cites W3144215568 @default.
• W4308015771 cites W4211055415 @default.
• W4308015771 cites W4212938637 @default.
• W4308015771 doi "https://doi.org/10.1371/journal.pone.0275392" @default.
• W4308015771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36318524" @default.
• W4308015771 hasPublicationYear "2022" @default.
• W4308015771 type Work @default.
• W4308015771 citedByCount "2" @default.
• W4308015771 countsByYear W43080157712023 @default.
• W4308015771 crossrefType "journal-article" @default.
• W4308015771 hasAuthorship W4308015771A5045755790 @default.
• W4308015771 hasAuthorship W4308015771A5074133814 @default.
• W4308015771 hasAuthorship W4308015771A5080337025 @default.
• W4308015771 hasAuthorship W4308015771A5090814462 @default.
• W4308015771 hasBestOaLocation W43080157711 @default.
• W4308015771 hasConcept C126322002 @default.
• W4308015771 hasConcept C142724271 @default.
• W4308015771 hasConcept C168563851 @default.
• W4308015771 hasConcept C1862650 @default.
• W4308015771 hasConcept C204787440 @default.
• W4308015771 hasConcept C27081682 @default.
• W4308015771 hasConcept C2776478404 @default.
• W4308015771 hasConcept C2777466421 @default.
• W4308015771 hasConcept C2777628954 @default.
• W4308015771 hasConcept C2778963770 @default.
• W4308015771 hasConcept C2779820409 @default.
• W4308015771 hasConcept C2779881954 @default.
• W4308015771 hasConcept C2780404050 @default.
• W4308015771 hasConcept C3018348675 @default.
• W4308015771 hasConcept C71924100 @default.
• W4308015771 hasConcept C95190672 @default.
• W4308015771 hasConceptScore W4308015771C126322002 @default.
• W4308015771 hasConceptScore W4308015771C142724271 @default.
• W4308015771 hasConceptScore W4308015771C168563851 @default.
• W4308015771 hasConceptScore W4308015771C1862650 @default.
• W4308015771 hasConceptScore W4308015771C204787440 @default.
• W4308015771 hasConceptScore W4308015771C27081682 @default.
• W4308015771 hasConceptScore W4308015771C2776478404 @default.
• W4308015771 hasConceptScore W4308015771C2777466421 @default.
• W4308015771 hasConceptScore W4308015771C2777628954 @default.
• W4308015771 hasConceptScore W4308015771C2778963770 @default.
• W4308015771 hasConceptScore W4308015771C2779820409 @default.
• W4308015771 hasConceptScore W4308015771C2779881954 @default.
• W4308015771 hasConceptScore W4308015771C2780404050 @default.
• W4308015771 hasConceptScore W4308015771C3018348675 @default.
• W4308015771 hasConceptScore W4308015771C71924100 @default.
• W4308015771 hasConceptScore W4308015771C95190672 @default.
• W4308015771 hasFunder F4320321001 @default.

• next